National & International Grants

National & International Grants

Nationally Funded Projects

ZF GGAA landscape CCRI responsible principal investigator: Niko Popitsch Grant from the Austrian Research Promotion Agency (FFG), Call Talente FEMTech Praktika Studentinnen 2018 Duration: 01/08/2018 to 30/09/2018 Phylogenetic analysis of primary and disseminated tumor cells to reconstruct the metastatic route of relapsed neuroblastomas CCRI responsible principal investigator: Reza Abbasi Grant from the Ingrid Shaker Nessmann Krebsforschungsvereinigung (ISNK) – Forschungsförderung 2018 Duration: 01/02/2018 to 31/01/2019 Analysis of temporal and spatial Ewing sarcoma tumor evolution during chemotherapy and validation of its clinical implication CCRI coordinator: Eleni Tomazou Grant from the Austrian National Bank (OeNB), Jubiläumsfonds Duration: 01/09/2018 to 31/08/2021 Platform supporting an integrated analysis of image and multiOMICs data based on liquid biopsies for tumor diagnostics (VISIOMICS) Labdia Coordinator: Sabine Taschner-Mandl, Peter Ambros Grant from the Austrian Research Promotion Agency (FFG), COIN Programme Duration: 01/11/2017 to 31/10/2019 Establishing a zebrafish disease model drug screening platform, (Danio4Can) CCRI responsible principal investigator: Martin Distel Grant from the Austrian Research Promotion Agency (FFG), R&D Infrastrukturförderung, 1st Call Duration: 01/05/2017 to 30/04/2019 Role of stress granules in Ewing sarcoma susceptibility CCRI responsible principal investigator: Heinrich Kovar Grant from the Austrian Science Fund (FWF), Stand Alone Project Duration: 01/06/2017 to 31/05/2020 Overcoming Neuroblastoma Tumour HETerogeneity, Resistance and RecurrAnCe (ONTHETRRAC) CCRI responsible principal investigator: Peter Ambros Grant from the Austrian Science Fund (FWF), ERA-Net Transcan Duration: 01/01/2016 to 30/09/2018 Ewing sarcoma – an enhancer disease? CCRI responsible principal investigator: Eleni Tomazou Grant from the Austrian Science Fund (FWF), Elise Richter Programme Duration: 01/01/2016 to 31/12/2019 TRANSCALL (Translational research in childhood acute lymphoblastic leukemia) CCRI responsible principal investigator: Renate Panzer-Grümayer Grant from the Austrian Science Fund (FWF), ERA-Net Transcan Duration: 01/07/2013 to 30/06/2017 PROVABES (prospective validation of biomarkers in Ewing sarcoma for personalized treatment) CCRI responsible principal investigator: Heinrich Kovar Grant from the Austrian Science Fund (FWF), ERA-Net Transcan Duration: 01/04/2013 to 31/03/2017 Myeloproliferative neoplasms CCRI partner: Thomas Lion Coordinator: Peter Valent (Medical University of Vienna, Austria) Grant from the Austrian Science Fund (FWF), Special Research Programme (SFB) Duration: 01/03/2013 to 28/02/2017 Verfahren zur hochautomatisierten Bewertung und Klassifikation von Zellen in Gewebeschnitten anhand räumlicher Markerprofile (TisQuant) LABDIA responsible principal investigator: Peter Ambros Grant from the Austrian Research Promotion Agency (FFG), ERA-SME Duration: 01/06/2014 to 31/05/2017 Directed in vitro differentiation of induced pluripotent stem cells towards the B lymphoid lineage (B-different) CCRI coordinator: Klaus Fortschegger Grant from the Austrian Research Promotion Agency (FFG), Call Bridge (Brückenschlagprogramm) Duration: 01/06/2014 to 22/12/2017 Virus-specific immunotherapy (VISIT) CCRI/Labdia: coordinator René Geyeregger (Labdia), partner: Matthes-Leodolter (CCRI) Grant from the Wirtschaftsagentur Wien, Call Life Sciences 2014 Duration: 01/04/2015 to 31/03/2018 Automated MRD-assessment in AML (flowCLUSTER) Labdia coordinator: Michael Dworzak Grant from the Wirtschaftsagentur Wien, Call Life Sciences 2014 Duration: 01/03/2015 to 28/02/2018 Liquid biopsy in neuroblastoma: chance for diagnosis, prognosis and disease monitoring CCRI responsible principal investigator: Peter Ambros Grant from the Austrian National Bank (OeNB), Jubiläumsfonds Duration: 01/01/2016 to 30/09/2018 Permanent consequences in childhood Langerhans cell histiocytosis CCRI responsible principal investigator: Milen Minkov Grant from the Austrian National Bank (OeNB), Jubiläumsfonds Duration: 01/09/2015 to 31/12/2018 Verbesserte Patientenkommunikation in der Onkologie mittels INTERACCT App (OCCURSUS) CCRI responsible principal investigator: Anita Lawitschka Grant from the „Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie“ Duration: 01/05/2016 to 31/07/2017

Internationally Funded Projects

PRedictive In-silico Multiscale Analytics (PRIMAGE) CCRI responsible principal investigator: Ruth Ladenstein European Commission Grant – Call H2020-SC1-DTH-2018-2020 Duration: 01/12/2018 to 30/11/2022 Integrated European Network on cGvHD CCRI responsible principal investigator: Anita Lawitschka European Commission Grant – COST Action Duration: 31/08/2018 to 30/08/2022 ERN-PAEDCAN-CEF-Telecom CCRI Coordinator: Ruth Ladenstein European Commission Grant – Call CEF-TC-2017-2 Duration: 01/05/2018 to 31/08/2019 ERN-PAEDCAN Partner: Paediatric Rare Tumours Network - European Registry (PARTNER) CCRI responsible principal investigator: Ruth Ladenstein European Commission Grant – Call CEF-TC-2017-2 Duration: 01/01/2018 to 31/12/2020 Paediatric Cancer European Reference Network (ERN PaedCan) CCRI Coordinator: Ruth Ladenstein Grant from the European Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) Duration: 01/03/2017 to 28/02/2022 ITCC Pediatric Preclinical POC Platform (ITCCP4) CCRI partner: Heinrich Kovar Coordinator: Stefan Pfister (Deutsches Krebsforschungszentrum DKFZ, Germany) European Commission Grant – H2020 Innovative Medicines Initiative Duration: 01/01/2017 to 31/12/2021 Optimized diagnostics for improved treatment stratification in invasive fungal diseases (FUNGITECT) CCRI/Labdia Coordinator: Thomas Lion European Commission Grant – FP7 Cooperation Project Duration: 01/02/2014 to 31/01/2019 Automation of flow cytometric analysis for quality-assured follow-up assessment to guide curative therapy for acute lymphoblastic leukaemia in children (AutoFLOW) CCRI/Labdia partner: Michael Dworzak Coordinator: Martin Kampel (Technical University of Vienna, Austria) European Commission Grant – FP7 Industry-Academia Partnerships and Pathways (Marie Curie Actions) Duration: 01/02/2014 to 31/12/2017 EURO EWING Consortium – International clinical trials to improve survival from Ewing sarcoma (EEC) CCRI partner: Heinrich Kovar Coordinator: Jeremy Whelan (University College London, UK) European Commission Grant – FP7 Cooperation Project Duration: 01/10/2013 to 31/12/2018 Molecular mechanisms of human fungal pathogen host interaction (ImResFun) CCRI partner: Thomas Lion Coordinator: Karl Kuchler (Medical University of Vienna, Austria) European Commission Grant – FP7 Initial Training Network (Marie Curie Actions) Duration: 01/10/2013 to 30/08/2017 Expert paediatric oncology reference network for diagnostics and treatment (ExPO-r-Net) CCRI Coordinator: Ruth Ladenstein Grant from the European Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) Duration: 01/03/2014 to 31/08/2017 International study for treatment of childhood relapsed ALL 2010 (IntReALL) CCRI partners: Georg Mann, Andishe Attarbaschi and Ruth Ladenstein Coordinator: Jeremy Whelan (University College London, UK) European Commission Grant – FP7 Cooperation Project Duration: 01/10/2011 to 30/09/2017 PanCare childhood and adolescent cancer survivor care and follow-up studies (PanCareSurFup) CCRI/St Anna Spital partners: Eva Frey Coordinator: Lars Hjorth (Lund University, Sweden) European Commission Grant – FP7 Cooperation Project Duration: 01/02/2011 to 10/02/2017